Clinical Trial Update: Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study [Phase 2]

View source ↗

Summary

This Phase 2 pilot study investigated novel mechanisms of vaccine failure in a live attenuated influenza vaccine (LAIV) program and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Acquired Immune Deficiency Syndrome Virus | Phase 2 | Status: COMPLETED